Literature DB >> 21252689

Surgical burn wound infections and their clinical implications.

Joseph A Posluszny1, Peggie Conrad, Marcia Halerz, Ravi Shankar, Richard L Gamelli.   

Abstract

Typically, burn wound infections are classified by the organisms present in the wound within the first several days after injury or later by routine surveillance cultures. With universal acceptance of early excision and grafting, classification of burn wound colonization in unexcised burn wounds is less relevant, shifting clinical significance to open burn-related surgical wound infections (SWIs). To better characterize SWIs and their clinical relevance, the authors identified the pathogens responsible for SWIs, their impact on rates of regrafting, and the relationship between SWI and nosocomial infection (NI) pathogens. Epidemiologic and clinical data for 71 adult patients with ≥ 20% TBSA burn were collected. After excision and grafting, if a grafted site had clinical characteristics of infection, a wound culture swab was obtained and the organism identified. Surveillance cultures were not obtained. SWI pathogen, anatomic location, postburn day of occurrence, and need for regrafting were compiled. A positive culture obtained from an isolated anatomic location at any time point after excision and grafting of that location was considered a distinct infection. Pathogens responsible for NIs (urinary tract infections, pneumonia, bloodstream and catheter-related bloodstream infections, pseudomembranous colitis, and donor site infections) and their postburn day were identified. The profiles of SWI pathogens and NI pathogens were then compared. Of the 71 patients included, 2 withdrew, 6 had no excision or grafting performed, and 1 had incomplete data. Of the remaining 62 patients, 24 (39%) developed an SWI. In these 24 patients, 70 distinct infections were identified, of which 46% required regrafting. Candida species (24%), Pseudomonas aeruginosa (22%), Serratia marcescens (11%), and Staphylococcus aureus (11%) comprised the majority of pathogens. Development of an SWI with the need for regrafting increased overall length of stay, area of autograft, number of operative events, and was closely associated with the number of NIs. The %TBSA burn and depth of the burn were the main risk factors for SWI with need for regrafting. The SWI pathogen was identified as an NI pathogen 56% of the time, with no temporal correlation between shared SWI and NI pathogens. SWIs are commonly found in severely burned patients and are associated with regrafting. As a result, patients with SWIs are subjected to increased operative events, autograft placement, and increased length of hospitalization. In addition, the presence of an SWI may be a risk factor for development of NIs.

Entities:  

Mesh:

Year:  2011        PMID: 21252689      PMCID: PMC3056080          DOI: 10.1097/BCR.0b013e31820aaffe

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  29 in total

1.  Inflammation and the host response to injury: an overview of the multicenter study of the genomic and proteomic response to burn injury.

Authors:  Matthew B Klein; Geoff Silver; Richard L Gamelli; Nicole S Gibran; David N Herndon; John L Hunt; Ronald G Tompkins
Journal:  J Burn Care Res       Date:  2006 Jul-Aug       Impact factor: 1.845

2.  Infections in burn patients--experience in a tertiary care hospital.

Authors:  Mathangi K Ramakrishnan; Janani Sankar; Jayaraman Venkatraman; Jayanthi Ramesh
Journal:  Burns       Date:  2006-05-19       Impact factor: 2.744

Review 3.  Meta-analysis of early excision of burns.

Authors:  Yee Siang Ong; Miny Samuel; Colin Song
Journal:  Burns       Date:  2006-01-18       Impact factor: 2.744

Review 4.  Systematic review of skin graft donor-site dressings.

Authors:  Sophocles H Voineskos; Olubimpe A Ayeni; Leslie McKnight; Achilleas Thoma
Journal:  Plast Reconstr Surg       Date:  2009-07       Impact factor: 4.730

5.  Surveillance of burn wound infections: a proposal for definitions.

Authors:  M D Peck; J Weber; A McManus; R Sheridan; D Heimbach
Journal:  J Burn Care Rehabil       Date:  1998 Sep-Oct

Review 6.  Burn wound infections: current status.

Authors:  B A Pruitt; A T McManus; S H Kim; C W Goodwin
Journal:  World J Surg       Date:  1998-02       Impact factor: 3.352

Review 7.  Burn wound infections.

Authors:  Deirdre Church; Sameer Elsayed; Owen Reid; Brent Winston; Robert Lindsay
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

8.  American Burn Association consensus conference to define sepsis and infection in burns.

Authors:  David G Greenhalgh; Jeffrey R Saffle; James H Holmes; Richard L Gamelli; Tina L Palmieri; Jureta W Horton; Ronald G Tompkins; Daniel L Traber; David W Mozingo; Edwin A Deitch; Cleon W Goodwin; David N Herndon; James J Gallagher; Art P Sanford; James C Jeng; David H Ahrenholz; Alice N Neely; Michael S O'Mara; Steven E Wolf; Gary F Purdue; Warren L Garner; Charles J Yowler; Barbara A Latenser
Journal:  J Burn Care Res       Date:  2007 Nov-Dec       Impact factor: 1.845

9.  Fungal wound infection (not colonization) is independently associated with mortality in burn patients.

Authors:  Edward E Horvath; Clinton K Murray; George M Vaughan; Kevin K Chung; Duane R Hospenthal; Charles E Wade; John B Holcomb; Steven E Wolf; Arthur D Mason; Leopoldo C Cancio
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

10.  Positive fungal cultures in burn patients: a multicenter review.

Authors:  James Ballard; Linda Edelman; Jeffrey Saffle; Robert Sheridan; Richard Kagan; D Bracco; Leopoldo Cancio; Bruce Cairns; Rose Baker; Paula Fillari; Lucy Wibbenmeyer; David Voight; Tina Palmieri; David Greenhalgh; Nathan Kemalyan; Daniel Caruso
Journal:  J Burn Care Res       Date:  2008 Jan-Feb       Impact factor: 1.845

View more
  10 in total

1.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

Review 2.  Management and prevention of drug resistant infections in burn patients.

Authors:  Roohi Vinaik; Dalia Barayan; Shahriar Shahrokhi; Marc G Jeschke
Journal:  Expert Rev Anti Infect Ther       Date:  2019-08-04       Impact factor: 5.091

3.  One-hit wonder: Late after burn injury, granulocytes can clear one bacterial infection but cannot control a subsequent infection.

Authors:  Laurel B Kartchner; Cindy J Gode; Julia L M Dunn; Lindsey I Glenn; Danté N Duncan; Matthew C Wolfgang; Bruce A Cairns; Robert Maile
Journal:  Burns       Date:  2019-03-02       Impact factor: 2.744

4.  Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.

Authors:  Kyle G Miller; Phat L Tran; Cecily L Haley; Cassandra Kruzek; Jane A Colmer-Hamood; Matt Myntti; Abdul N Hamood
Journal:  Antimicrob Agents Chemother       Date:  2014-03-17       Impact factor: 5.191

5.  Serratia marcescens osteomyelitis in Cushing's disease.

Authors:  Hugo F G Martins; Alexandra Raposo; Isabel Baptista; Julio Almeida
Journal:  BMJ Case Rep       Date:  2015-11-30

6.  Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns.

Authors:  Stefan Bohr; Suraj J Patel; Keyue Shen; Antonia G Vitalo; Michael Brines; Anthony Cerami; Francois Berthiaume; Martin L Yarmush
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

7.  Infection control in severely burned patients.

Authors:  Yusuf Kenan Coban
Journal:  World J Crit Care Med       Date:  2012-08-04

8.  Zinc Pyrithione Improves the Antibacterial Activity of Silver Sulfadiazine Ointment.

Authors:  Catlyn Blanchard; Lauren Brooks; Katherine Ebsworth-Mojica; Louis Didione; Benjamin Wucher; Stephen Dewhurst; Damian Krysan; Paul M Dunman; Rachel A F Wozniak
Journal:  mSphere       Date:  2016-09-14       Impact factor: 4.389

9.  Protocol for the development of a core indicator set for reporting burn wound infection in trials: ICon-B study.

Authors:  Anna Davies; Louise Teare; Sian Falder; Karen Coy; Jo C Dumville; Declan Collins; Luke Moore; Baljit Dheansa; A Toby A Jenkins; Simon Booth; Riaz Agha; Mamta Shah; Karen Marlow; Amber Young
Journal:  BMJ Open       Date:  2019-05-14       Impact factor: 2.692

10.  Xylitol Inhibits Growth and Blocks Virulence in Serratia marcescens.

Authors:  Ahdab N Khayyat; Wael A H Hegazy; Moataz A Shaldam; Rasha Mosbah; Ahmad J Almalki; Tarek S Ibrahim; Maan T Khayat; El-Sayed Khafagy; Wafaa E Soliman; Hisham A Abbas
Journal:  Microorganisms       Date:  2021-05-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.